NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Emerging Infectious Diseases from the Global to the Local Perspective

Emerging Infectious Diseases from the Global to the Local Perspective

A Summary of a Workshop of the Forum on Emerging Infections

; Editors: Jonathan R Davis and Joshua Lederberg.

Washington (DC): National Academies Press (US); .
ISBN-10: 0-309-07184-4

Excerpt

In October 1999, the Forum on Emerging Infections of the Institute of Medicine convened a 2-day workshop titled “International Aspects of Emerging Infections.” Key representatives from the international community explored the forces that drive emerging infectious diseases to prominence. Representatives from the Americas, Africa, Asia and the Pacific, and Europe made formal presentations and engaged in panel discussions. Summaries of the formal presentations can be found in Chapter 1, Chapter 2, Chapter 3, Chapter 4 through Chapter 5 of this report. The topics addressed during this conference cover a wide range of issues, including trends in the incidence of infectious diseases around the world, descriptions of the wide variety of factors that contribute to the emergence and reemergence of these diseases, efforts to coordinate surveillance activities and responses within and across borders, and the resource, research, and international needs that remain to be addressed.

Contents

This report is based on the proceedings of a workshop that was sponsored by the Forum on Emerging Infections. It is prepared in the form of a workshop summary by and in the name of the editors, with the assistance of staff and consultants, as an individually authored document. Sections of the workshop summary not specifically attributed to an individual reflect the views of the editors and not those of the Forum on Emerging Infections. The content of those sections is based on the presentations and the discussions that took place during the workshop.

Support for this project was provided by the U.S. Department of Health and Human Services’ National Institutes of Health, Centers for Disease Control and Prevention, and U.S. Food and Drug Administration; U.S. Department of Defense; U.S. Department of State; U.S. Department of Veterans Affairs; Abbott Laboratories; American Society for Microbiology; Bristol-Myers Squibb Company; Burroughs Wellcome Fund; Eli Lilly & Company; Glaxo Wellcome; F. Hoffmann-La Roche, AG; Pfizer, Inc.; SmithKline Beecham Corporation; and Wyeth-Ayerst Laboratories.

The views presented are those of the editors and workshop participants and are not necessarily those of the funding organizations.

NOTICE: The project that is the subject of this workshop summary was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Copyright © 2001, National Academy of Sciences.
Bookshelf ID: NBK99571PMID: 22896870DOI: 10.17226/10084

Views

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...